Hemogenyx Liabilities And Stockholders Equity from 2010 to 2024

HEMO Stock   343.40  20.90  6.48%   
Hemogenyx Pharmaceuticals Liabilities And Stockholders Equity yearly trend continues to be comparatively stable with very little volatility. Liabilities And Stockholders Equity will likely drop to about 3.5 M in 2024. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Hemogenyx Pharmaceuticals' total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2016-06-30
Previous Quarter
6.1 M
Current Value
6.1 M
Quarterly Volatility
3.3 M
 
Covid
Check Hemogenyx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hemogenyx Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 365.3 K, Selling General Administrative of 5.2 M or Other Operating Expenses of 6.8 M, as well as many indicators such as . Hemogenyx financial statements analysis is a perfect complement when working with Hemogenyx Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Hemogenyx Pharmaceuticals Technical models . Check out the analysis of Hemogenyx Pharmaceuticals Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hemogenyx Stock Analysis

When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.